Biotechnology

Lux Capital

Kalish’s role at Lux is centered on capital formation rather than direct investing. Lux says he focuses on building long-term investor relationships grounded in transparency and trust, and on helping portfolio companies grow through high-value introductions, partnerships, and fundraising connections.